nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ALB—ulcerative colitis	0.232	0.512	CbGaD
Canagliflozin—ABCB1—ulcerative colitis	0.222	0.488	CbGaD
Canagliflozin—ABCC2—Sulfasalazine—ulcerative colitis	0.0608	0.169	CbGbCtD
Canagliflozin—CYP3A4—Budesonide—ulcerative colitis	0.0351	0.0975	CbGbCtD
Canagliflozin—ABCC2—Dexamethasone—ulcerative colitis	0.0303	0.0843	CbGbCtD
Canagliflozin—ALB—Prednisone—ulcerative colitis	0.0303	0.0842	CbGbCtD
Canagliflozin—ABCB1—Methylprednisolone—ulcerative colitis	0.0261	0.0727	CbGbCtD
Canagliflozin—ABCB1—Betamethasone—ulcerative colitis	0.017	0.0473	CbGbCtD
Canagliflozin—ABCB1—Prednisolone—ulcerative colitis	0.0168	0.0466	CbGbCtD
Canagliflozin—ABCB1—Hydrocortisone—ulcerative colitis	0.0159	0.0442	CbGbCtD
Canagliflozin—ABCB1—Prednisone—ulcerative colitis	0.0158	0.044	CbGbCtD
Canagliflozin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0157	0.0435	CbGbCtD
Canagliflozin—CYP3A4—Nicotine—ulcerative colitis	0.0153	0.0424	CbGbCtD
Canagliflozin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0137	0.0381	CbGbCtD
Canagliflozin—CYP3A4—Triamcinolone—ulcerative colitis	0.0119	0.033	CbGbCtD
Canagliflozin—ABCC2—bile duct—ulcerative colitis	0.011	0.224	CbGeAlD
Canagliflozin—ORM1—bile—ulcerative colitis	0.0103	0.21	CbGeAlD
Canagliflozin—CYP3A4—Betamethasone—ulcerative colitis	0.0102	0.0283	CbGbCtD
Canagliflozin—CYP3A4—Prednisolone—ulcerative colitis	0.0101	0.0279	CbGbCtD
Canagliflozin—ABCB1—Dexamethasone—ulcerative colitis	0.00989	0.0275	CbGbCtD
Canagliflozin—CYP3A4—Hydrocortisone—ulcerative colitis	0.00953	0.0265	CbGbCtD
Canagliflozin—CYP3A4—Prednisone—ulcerative colitis	0.00949	0.0264	CbGbCtD
Canagliflozin—ABCC2—bile—ulcerative colitis	0.00844	0.172	CbGeAlD
Canagliflozin—CYP3A4—Dexamethasone—ulcerative colitis	0.00593	0.0165	CbGbCtD
Canagliflozin—SLC5A1—epithelium—ulcerative colitis	0.00445	0.091	CbGeAlD
Canagliflozin—SLC5A1—digestive system—ulcerative colitis	0.00339	0.0692	CbGeAlD
Canagliflozin—UGT2B4—liver—ulcerative colitis	0.00233	0.0475	CbGeAlD
Canagliflozin—UGT1A9—digestive system—ulcerative colitis	0.00213	0.0436	CbGeAlD
Canagliflozin—UGT1A9—liver—ulcerative colitis	0.00159	0.0325	CbGeAlD
Canagliflozin—Dapagliflozin—ABCB1—ulcerative colitis	0.00147	1	CrCbGaD
Canagliflozin—ABCC2—digestive system—ulcerative colitis	0.000922	0.0188	CbGeAlD
Canagliflozin—SLC5A2—Carbohydrate metabolism—CHP1—ulcerative colitis	0.000861	0.0183	CbGpPWpGaD
Canagliflozin—ORM1—liver—ulcerative colitis	0.000836	0.0171	CbGeAlD
Canagliflozin—ALB—liver—ulcerative colitis	0.000733	0.015	CbGeAlD
Canagliflozin—UGT1A9—NRF2 pathway—SLC39A11—ulcerative colitis	0.00071	0.0151	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.0007	0.0149	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.0007	0.0149	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.0007	0.0149	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.0007	0.0149	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—SLC39A11—ulcerative colitis	0.000693	0.0147	CbGpPWpGaD
Canagliflozin—ABCC2—liver—ulcerative colitis	0.000687	0.014	CbGeAlD
Canagliflozin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00062	0.0132	CbGpPWpGaD
Canagliflozin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000618	0.0131	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000603	0.0128	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000603	0.0128	CbGpPWpGaD
Canagliflozin—CYP3A4—digestive system—ulcerative colitis	0.000468	0.00957	CbGeAlD
Canagliflozin—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000453	0.00962	CbGpPWpGaD
Canagliflozin—ABCB1—epithelium—ulcerative colitis	0.000436	0.00891	CbGeAlD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000436	0.00926	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000436	0.00926	CbGpPWpGaD
Canagliflozin—Breast disorder—Mesalazine—ulcerative colitis	0.000434	0.00489	CcSEcCtD
Canagliflozin—Dry mouth—Nicotine—ulcerative colitis	0.00043	0.00485	CcSEcCtD
Canagliflozin—Rash maculo-papular—Hydrocortisone—ulcerative colitis	0.000428	0.00482	CcSEcCtD
Canagliflozin—Skin disorder—Mercaptopurine—ulcerative colitis	0.000423	0.00476	CcSEcCtD
Canagliflozin—Shock—Nicotine—ulcerative colitis	0.000415	0.00467	CcSEcCtD
Canagliflozin—Nervous system disorder—Nicotine—ulcerative colitis	0.000414	0.00466	CcSEcCtD
Canagliflozin—Pancreatitis—Mesalazine—ulcerative colitis	0.000407	0.00459	CcSEcCtD
Canagliflozin—Urinary tract disorder—Budesonide—ulcerative colitis	0.000404	0.00455	CcSEcCtD
Canagliflozin—Diabetes mellitus—Prednisolone—ulcerative colitis	0.000402	0.00453	CcSEcCtD
Canagliflozin—Urethral disorder—Budesonide—ulcerative colitis	0.000401	0.00451	CcSEcCtD
Canagliflozin—Hypotension—Nicotine—ulcerative colitis	0.000394	0.00444	CcSEcCtD
Canagliflozin—Diabetes mellitus—Hydrocortisone—ulcerative colitis	0.000393	0.00443	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—PTGS1—ulcerative colitis	0.000385	0.00818	CbGpPWpGaD
Canagliflozin—Pollakiuria—Mesalazine—ulcerative colitis	0.000384	0.00432	CcSEcCtD
Canagliflozin—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000383	0.00814	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.00038	0.00808	CbGpPWpGaD
Canagliflozin—Photosensitivity reaction—Mesalazine—ulcerative colitis	0.000379	0.00427	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000376	0.00423	CcSEcCtD
Canagliflozin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000374	0.00794	CbGpPWpGaD
Canagliflozin—Angiopathy—Budesonide—ulcerative colitis	0.000371	0.00418	CcSEcCtD
Canagliflozin—Diabetes mellitus—Triamcinolone—ulcerative colitis	0.00037	0.00417	CcSEcCtD
Canagliflozin—Diabetes mellitus—Methylprednisolone—ulcerative colitis	0.000369	0.00416	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000364	0.0041	CcSEcCtD
Canagliflozin—Fatigue—Nicotine—ulcerative colitis	0.000364	0.0041	CcSEcCtD
Canagliflozin—Constipation—Nicotine—ulcerative colitis	0.000361	0.00406	CcSEcCtD
Canagliflozin—Urinary tract infection—Mesalazine—ulcerative colitis	0.00036	0.00405	CcSEcCtD
Canagliflozin—Malnutrition—Budesonide—ulcerative colitis	0.000356	0.00401	CcSEcCtD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000356	0.00757	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000356	0.00756	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000356	0.00756	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000356	0.00756	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000356	0.00756	CbGpPWpGaD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000355	0.00755	CbGpPWpGaD
Canagliflozin—CYP3A4—liver—ulcerative colitis	0.000349	0.00713	CbGeAlD
Canagliflozin—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000345	0.00388	CcSEcCtD
Canagliflozin—ABCC2—ABC-family proteins mediated transport—ABCB1—ulcerative colitis	0.00034	0.00723	CbGpPWpGaD
Canagliflozin—Diabetes mellitus—Dexamethasone—ulcerative colitis	0.000336	0.00378	CcSEcCtD
Canagliflozin—Diabetes mellitus—Betamethasone—ulcerative colitis	0.000336	0.00378	CcSEcCtD
Canagliflozin—ABCB1—lymphoid tissue—ulcerative colitis	0.000336	0.00686	CbGeAlD
Canagliflozin—Urticaria—Nicotine—ulcerative colitis	0.000335	0.00377	CcSEcCtD
Canagliflozin—Abdominal pain—Nicotine—ulcerative colitis	0.000333	0.00375	CcSEcCtD
Canagliflozin—ABCB1—digestive system—ulcerative colitis	0.000332	0.00678	CbGeAlD
Canagliflozin—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000328	0.0037	CcSEcCtD
Canagliflozin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000328	0.00697	CbGpPWpGaD
Canagliflozin—Urethral disorder—Mesalazine—ulcerative colitis	0.000326	0.00367	CcSEcCtD
Canagliflozin—Angioedema—Budesonide—ulcerative colitis	0.000325	0.00366	CcSEcCtD
Canagliflozin—SLC5A1—Carbohydrate metabolism—CALM3—ulcerative colitis	0.000323	0.00688	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—CALM3—ulcerative colitis	0.000323	0.00688	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000321	0.00361	CcSEcCtD
Canagliflozin—Syncope—Budesonide—ulcerative colitis	0.000319	0.00359	CcSEcCtD
Canagliflozin—Loss of consciousness—Budesonide—ulcerative colitis	0.000313	0.00352	CcSEcCtD
Canagliflozin—Hypersensitivity—Nicotine—ulcerative colitis	0.000311	0.0035	CcSEcCtD
Canagliflozin—Asthenia—Nicotine—ulcerative colitis	0.000303	0.00341	CcSEcCtD
Canagliflozin—Angiopathy—Mesalazine—ulcerative colitis	0.000302	0.0034	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000301	0.00339	CcSEcCtD
Canagliflozin—Pruritus—Nicotine—ulcerative colitis	0.000298	0.00336	CcSEcCtD
Canagliflozin—Pancreatitis—Prednisolone—ulcerative colitis	0.000297	0.00334	CcSEcCtD
Canagliflozin—Dry mouth—Budesonide—ulcerative colitis	0.000296	0.00334	CcSEcCtD
Canagliflozin—Diabetes mellitus—Prednisone—ulcerative colitis	0.000292	0.00329	CcSEcCtD
Canagliflozin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000291	0.00618	CbGpPWpGaD
Canagliflozin—Breast disorder—Methylprednisolone—ulcerative colitis	0.00029	0.00327	CcSEcCtD
Canagliflozin—Pancreatitis—Hydrocortisone—ulcerative colitis	0.00029	0.00326	CcSEcCtD
Canagliflozin—Erythema—Mesalazine—ulcerative colitis	0.00029	0.00326	CcSEcCtD
Canagliflozin—Infection—Budesonide—ulcerative colitis	0.000289	0.00325	CcSEcCtD
Canagliflozin—Shock—Budesonide—ulcerative colitis	0.000286	0.00322	CcSEcCtD
Canagliflozin—Nervous system disorder—Budesonide—ulcerative colitis	0.000285	0.00321	CcSEcCtD
Canagliflozin—Skin disorder—Budesonide—ulcerative colitis	0.000282	0.00318	CcSEcCtD
Canagliflozin—Dizziness—Nicotine—ulcerative colitis	0.000279	0.00314	CcSEcCtD
Canagliflozin—Rash—Mercaptopurine—ulcerative colitis	0.000274	0.00309	CcSEcCtD
Canagliflozin—Dermatitis—Mercaptopurine—ulcerative colitis	0.000274	0.00309	CcSEcCtD
Canagliflozin—Pancreatitis—Triamcinolone—ulcerative colitis	0.000273	0.00307	CcSEcCtD
Canagliflozin—Pancreatitis—Methylprednisolone—ulcerative colitis	0.000272	0.00306	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000269	0.00303	CcSEcCtD
Canagliflozin—Rash—Nicotine—ulcerative colitis	0.000266	0.00299	CcSEcCtD
Canagliflozin—Dermatitis—Nicotine—ulcerative colitis	0.000266	0.00299	CcSEcCtD
Canagliflozin—Angioedema—Mesalazine—ulcerative colitis	0.000265	0.00298	CcSEcCtD
Canagliflozin—Syncope—Mesalazine—ulcerative colitis	0.00026	0.00292	CcSEcCtD
Canagliflozin—Nausea—Mercaptopurine—ulcerative colitis	0.000259	0.00291	CcSEcCtD
Canagliflozin—Infection—Azathioprine—ulcerative colitis	0.000258	0.0029	CcSEcCtD
Canagliflozin—Loss of consciousness—Mesalazine—ulcerative colitis	0.000254	0.00287	CcSEcCtD
Canagliflozin—Skin disorder—Azathioprine—ulcerative colitis	0.000252	0.00284	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000251	0.00282	CcSEcCtD
Canagliflozin—Nausea—Nicotine—ulcerative colitis	0.000251	0.00282	CcSEcCtD
Canagliflozin—Fatigue—Budesonide—ulcerative colitis	0.00025	0.00282	CcSEcCtD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—ulcerative colitis	0.000249	0.00529	CbGpPWpGaD
Canagliflozin—Constipation—Budesonide—ulcerative colitis	0.000248	0.0028	CcSEcCtD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000248	0.00526	CbGpPWpGaD
Canagliflozin—ABCB1—liver—ulcerative colitis	0.000247	0.00505	CbGeAlD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000245	0.00276	CcSEcCtD
Canagliflozin—SLC5A2—Disease—CHP1—ulcerative colitis	0.000244	0.00518	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CHP1—ulcerative colitis	0.000244	0.00518	CbGpPWpGaD
Canagliflozin—Hypotension—Azathioprine—ulcerative colitis	0.000242	0.00273	CcSEcCtD
Canagliflozin—Dry mouth—Mesalazine—ulcerative colitis	0.000241	0.00271	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000238	0.00268	CcSEcCtD
Canagliflozin—Infection—Mesalazine—ulcerative colitis	0.000235	0.00264	CcSEcCtD
Canagliflozin—Shock—Mesalazine—ulcerative colitis	0.000232	0.00262	CcSEcCtD
Canagliflozin—Nervous system disorder—Mesalazine—ulcerative colitis	0.000232	0.00261	CcSEcCtD
Canagliflozin—Urticaria—Budesonide—ulcerative colitis	0.000231	0.0026	CcSEcCtD
Canagliflozin—Abdominal pain—Budesonide—ulcerative colitis	0.00023	0.00259	CcSEcCtD
Canagliflozin—Skin disorder—Mesalazine—ulcerative colitis	0.000229	0.00258	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000224	0.00252	CcSEcCtD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000221	0.00471	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000221	0.00471	CbGpPWpGaD
Canagliflozin—Hypotension—Mesalazine—ulcerative colitis	0.000221	0.00249	CcSEcCtD
Canagliflozin—Pancreatitis—Prednisone—ulcerative colitis	0.000216	0.00243	CcSEcCtD
Canagliflozin—ALB—Vitamin B12 Metabolism—MPO—ulcerative colitis	0.000214	0.00455	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Budesonide—ulcerative colitis	0.000214	0.00241	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000212	0.00239	CcSEcCtD
Canagliflozin—Erythema—Prednisolone—ulcerative colitis	0.000211	0.00237	CcSEcCtD
Canagliflozin—Asthenia—Budesonide—ulcerative colitis	0.000208	0.00235	CcSEcCtD
Canagliflozin—Erythema—Hydrocortisone—ulcerative colitis	0.000206	0.00232	CcSEcCtD
Canagliflozin—Malnutrition—Hydrocortisone—ulcerative colitis	0.000206	0.00232	CcSEcCtD
Canagliflozin—Pruritus—Budesonide—ulcerative colitis	0.000206	0.00231	CcSEcCtD
Canagliflozin—Abdominal pain—Azathioprine—ulcerative colitis	0.000205	0.00231	CcSEcCtD
Canagliflozin—SLC5A2—Metabolism—CHP1—ulcerative colitis	0.000204	0.00434	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CHP1—ulcerative colitis	0.000204	0.00434	CbGpPWpGaD
Canagliflozin—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000204	0.0023	CcSEcCtD
Canagliflozin—Fatigue—Mesalazine—ulcerative colitis	0.000204	0.00229	CcSEcCtD
Canagliflozin—Constipation—Mesalazine—ulcerative colitis	0.000202	0.00228	CcSEcCtD
Canagliflozin—Angiopathy—Methylprednisolone—ulcerative colitis	0.000202	0.00227	CcSEcCtD
Canagliflozin—Erythema—Triamcinolone—ulcerative colitis	0.000194	0.00218	CcSEcCtD
Canagliflozin—SLC5A2—Disease—SEL1L—ulcerative colitis	0.000194	0.00412	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—SEL1L—ulcerative colitis	0.000194	0.00412	CbGpPWpGaD
Canagliflozin—Malnutrition—Methylprednisolone—ulcerative colitis	0.000193	0.00218	CcSEcCtD
Canagliflozin—Erythema—Methylprednisolone—ulcerative colitis	0.000193	0.00218	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000193	0.00218	CcSEcCtD
Canagliflozin—Angioedema—Prednisolone—ulcerative colitis	0.000193	0.00217	CcSEcCtD
Canagliflozin—Dizziness—Budesonide—ulcerative colitis	0.000192	0.00216	CcSEcCtD
Canagliflozin—Hypersensitivity—Azathioprine—ulcerative colitis	0.000191	0.00215	CcSEcCtD
Canagliflozin—Syncope—Prednisolone—ulcerative colitis	0.000189	0.00213	CcSEcCtD
Canagliflozin—Angioedema—Hydrocortisone—ulcerative colitis	0.000188	0.00212	CcSEcCtD
Canagliflozin—Urticaria—Mesalazine—ulcerative colitis	0.000188	0.00211	CcSEcCtD
Canagliflozin—Abdominal pain—Mesalazine—ulcerative colitis	0.000187	0.0021	CcSEcCtD
Canagliflozin—Loss of consciousness—Prednisolone—ulcerative colitis	0.000185	0.00209	CcSEcCtD
Canagliflozin—Syncope—Hydrocortisone—ulcerative colitis	0.000185	0.00208	CcSEcCtD
Canagliflozin—Angiopathy—Betamethasone—ulcerative colitis	0.000183	0.00206	CcSEcCtD
Canagliflozin—Angiopathy—Dexamethasone—ulcerative colitis	0.000183	0.00206	CcSEcCtD
Canagliflozin—Rash—Budesonide—ulcerative colitis	0.000183	0.00206	CcSEcCtD
Canagliflozin—Dermatitis—Budesonide—ulcerative colitis	0.000183	0.00206	CcSEcCtD
Canagliflozin—Convulsion—Prednisolone—ulcerative colitis	0.000183	0.00206	CcSEcCtD
Canagliflozin—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000181	0.00204	CcSEcCtD
Canagliflozin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00018	0.00382	CbGpPWpGaD
Canagliflozin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000179	0.00381	CbGpPWpGaD
Canagliflozin—Convulsion—Hydrocortisone—ulcerative colitis	0.000178	0.00201	CcSEcCtD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000178	0.00377	CbGpPWpGaD
Canagliflozin—Angioedema—Triamcinolone—ulcerative colitis	0.000177	0.00199	CcSEcCtD
Canagliflozin—Angioedema—Methylprednisolone—ulcerative colitis	0.000177	0.00199	CcSEcCtD
Canagliflozin—SLC5A2—Metabolism—DLD—ulcerative colitis	0.000176	0.00375	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—DLD—ulcerative colitis	0.000176	0.00375	CbGpPWpGaD
Canagliflozin—Erythema—Betamethasone—ulcerative colitis	0.000176	0.00198	CcSEcCtD
Canagliflozin—Erythema—Dexamethasone—ulcerative colitis	0.000176	0.00198	CcSEcCtD
Canagliflozin—ALB—Folate Metabolism—MPO—ulcerative colitis	0.000174	0.00371	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000174	0.00196	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000174	0.00196	CcSEcCtD
Canagliflozin—Syncope—Triamcinolone—ulcerative colitis	0.000174	0.00196	CcSEcCtD
Canagliflozin—SLC5A1—Disease—LTF—ulcerative colitis	0.000174	0.00369	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—LTF—ulcerative colitis	0.000174	0.00369	CbGpPWpGaD
Canagliflozin—Syncope—Methylprednisolone—ulcerative colitis	0.000173	0.00195	CcSEcCtD
Canagliflozin—Nausea—Budesonide—ulcerative colitis	0.000173	0.00194	CcSEcCtD
Canagliflozin—Dizziness—Azathioprine—ulcerative colitis	0.000172	0.00193	CcSEcCtD
Canagliflozin—Loss of consciousness—Triamcinolone—ulcerative colitis	0.00017	0.00192	CcSEcCtD
Canagliflozin—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.00017	0.00191	CcSEcCtD
Canagliflozin—Asthenia—Mesalazine—ulcerative colitis	0.00017	0.00191	CcSEcCtD
Canagliflozin—Shock—Prednisolone—ulcerative colitis	0.000169	0.00191	CcSEcCtD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000168	0.00357	CbGpPWpGaD
Canagliflozin—Convulsion—Triamcinolone—ulcerative colitis	0.000168	0.00189	CcSEcCtD
Canagliflozin—Convulsion—Methylprednisolone—ulcerative colitis	0.000168	0.00189	CcSEcCtD
Canagliflozin—Pruritus—Mesalazine—ulcerative colitis	0.000167	0.00188	CcSEcCtD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000167	0.00355	CbGpPWpGaD
Canagliflozin—Infection—Hydrocortisone—ulcerative colitis	0.000167	0.00188	CcSEcCtD
Canagliflozin—Shock—Hydrocortisone—ulcerative colitis	0.000165	0.00186	CcSEcCtD
Canagliflozin—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000165	0.00186	CcSEcCtD
Canagliflozin—Rash—Azathioprine—ulcerative colitis	0.000164	0.00184	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000164	0.00184	CcSEcCtD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000164	0.00348	CbGpPWpGaD
Canagliflozin—Dermatitis—Azathioprine—ulcerative colitis	0.000163	0.00184	CcSEcCtD
Canagliflozin—Skin disorder—Hydrocortisone—ulcerative colitis	0.000163	0.00184	CcSEcCtD
Canagliflozin—Dry mouth—Triamcinolone—ulcerative colitis	0.000161	0.00182	CcSEcCtD
Canagliflozin—Angioedema—Dexamethasone—ulcerative colitis	0.000161	0.00181	CcSEcCtD
Canagliflozin—Angioedema—Betamethasone—ulcerative colitis	0.000161	0.00181	CcSEcCtD
Canagliflozin—Angiopathy—Prednisone—ulcerative colitis	0.00016	0.0018	CcSEcCtD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000158	0.00335	CbGpPWpGaD
Canagliflozin—Syncope—Betamethasone—ulcerative colitis	0.000158	0.00178	CcSEcCtD
Canagliflozin—Syncope—Dexamethasone—ulcerative colitis	0.000158	0.00178	CcSEcCtD
Canagliflozin—UGT2B4—Metabolism—CHP1—ulcerative colitis	0.000158	0.00335	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—TGFB1—ulcerative colitis	0.000157	0.00335	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—TGFB1—ulcerative colitis	0.000157	0.00335	CbGpPWpGaD
Canagliflozin—Infection—Triamcinolone—ulcerative colitis	0.000157	0.00177	CcSEcCtD
Canagliflozin—Hypotension—Hydrocortisone—ulcerative colitis	0.000157	0.00177	CcSEcCtD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000157	0.00333	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	0.000157	0.00333	CbGpPWpGaD
Canagliflozin—Infection—Methylprednisolone—ulcerative colitis	0.000157	0.00177	CcSEcCtD
Canagliflozin—Dizziness—Mesalazine—ulcerative colitis	0.000156	0.00176	CcSEcCtD
Canagliflozin—Shock—Triamcinolone—ulcerative colitis	0.000156	0.00175	CcSEcCtD
Canagliflozin—Shock—Methylprednisolone—ulcerative colitis	0.000155	0.00175	CcSEcCtD
Canagliflozin—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000155	0.00174	CcSEcCtD
Canagliflozin—Loss of consciousness—Betamethasone—ulcerative colitis	0.000155	0.00174	CcSEcCtD
Canagliflozin—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000155	0.00174	CcSEcCtD
Canagliflozin—Nausea—Azathioprine—ulcerative colitis	0.000154	0.00173	CcSEcCtD
Canagliflozin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000153	0.00173	CcSEcCtD
Canagliflozin—Erythema—Prednisone—ulcerative colitis	0.000153	0.00172	CcSEcCtD
Canagliflozin—Malnutrition—Prednisone—ulcerative colitis	0.000153	0.00172	CcSEcCtD
Canagliflozin—Convulsion—Dexamethasone—ulcerative colitis	0.000152	0.00172	CcSEcCtD
Canagliflozin—Convulsion—Betamethasone—ulcerative colitis	0.000152	0.00172	CcSEcCtD
Canagliflozin—Rash—Mesalazine—ulcerative colitis	0.000149	0.00168	CcSEcCtD
Canagliflozin—Dermatitis—Mesalazine—ulcerative colitis	0.000149	0.00168	CcSEcCtD
Canagliflozin—Hypotension—Methylprednisolone—ulcerative colitis	0.000147	0.00166	CcSEcCtD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000146	0.0031	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000145	0.00309	CbGpPWpGaD
Canagliflozin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000145	0.00163	CcSEcCtD
Canagliflozin—Fatigue—Hydrocortisone—ulcerative colitis	0.000145	0.00163	CcSEcCtD
Canagliflozin—Infection—Dexamethasone—ulcerative colitis	0.000143	0.00161	CcSEcCtD
Canagliflozin—Infection—Betamethasone—ulcerative colitis	0.000143	0.00161	CcSEcCtD
Canagliflozin—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	0.000142	0.00303	CbGpPWpGaD
Canagliflozin—Shock—Betamethasone—ulcerative colitis	0.000141	0.00159	CcSEcCtD
Canagliflozin—Shock—Dexamethasone—ulcerative colitis	0.000141	0.00159	CcSEcCtD
Canagliflozin—Nervous system disorder—Betamethasone—ulcerative colitis	0.000141	0.00159	CcSEcCtD
Canagliflozin—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000141	0.00159	CcSEcCtD
Canagliflozin—Nausea—Mesalazine—ulcerative colitis	0.00014	0.00158	CcSEcCtD
Canagliflozin—Angioedema—Prednisone—ulcerative colitis	0.00014	0.00158	CcSEcCtD
Canagliflozin—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000139	0.00294	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000137	0.00155	CcSEcCtD
Canagliflozin—Syncope—Prednisone—ulcerative colitis	0.000137	0.00155	CcSEcCtD
Canagliflozin—Urticaria—Prednisolone—ulcerative colitis	0.000137	0.00154	CcSEcCtD
Canagliflozin—Fatigue—Triamcinolone—ulcerative colitis	0.000136	0.00154	CcSEcCtD
Canagliflozin—UGT2B4—Metabolism—DLD—ulcerative colitis	0.000136	0.00289	CbGpPWpGaD
Canagliflozin—Fatigue—Methylprednisolone—ulcerative colitis	0.000136	0.00153	CcSEcCtD
Canagliflozin—Loss of consciousness—Prednisone—ulcerative colitis	0.000135	0.00152	CcSEcCtD
Canagliflozin—Hypotension—Dexamethasone—ulcerative colitis	0.000134	0.00151	CcSEcCtD
Canagliflozin—Hypotension—Betamethasone—ulcerative colitis	0.000134	0.00151	CcSEcCtD
Canagliflozin—Urticaria—Hydrocortisone—ulcerative colitis	0.000133	0.0015	CcSEcCtD
Canagliflozin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000133	0.0015	CcSEcCtD
Canagliflozin—Convulsion—Prednisone—ulcerative colitis	0.000133	0.00149	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.00013	0.00146	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000129	0.00145	CcSEcCtD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000128	0.00273	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000127	0.00271	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000127	0.00271	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	0.000127	0.00271	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000127	0.00143	CcSEcCtD
Canagliflozin—Urticaria—Triamcinolone—ulcerative colitis	0.000126	0.00142	CcSEcCtD
Canagliflozin—Urticaria—Methylprednisolone—ulcerative colitis	0.000125	0.00141	CcSEcCtD
Canagliflozin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000125	0.00141	CcSEcCtD
Canagliflozin—Infection—Prednisone—ulcerative colitis	0.000124	0.0014	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000124	0.0014	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000124	0.0014	CcSEcCtD
Canagliflozin—ALB—Platelet degranulation—CALM3—ulcerative colitis	0.000124	0.00263	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—SLC11A1—ulcerative colitis	0.000124	0.00263	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—SLC11A1—ulcerative colitis	0.000124	0.00263	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000124	0.00139	CcSEcCtD
Canagliflozin—Fatigue—Dexamethasone—ulcerative colitis	0.000124	0.00139	CcSEcCtD
Canagliflozin—Fatigue—Betamethasone—ulcerative colitis	0.000124	0.00139	CcSEcCtD
Canagliflozin—Shock—Prednisone—ulcerative colitis	0.000123	0.00138	CcSEcCtD
Canagliflozin—Nervous system disorder—Prednisone—ulcerative colitis	0.000123	0.00138	CcSEcCtD
Canagliflozin—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000122	0.00259	CbGpPWpGaD
Canagliflozin—Skin disorder—Prednisone—ulcerative colitis	0.000121	0.00137	CcSEcCtD
Canagliflozin—Asthenia—Hydrocortisone—ulcerative colitis	0.000121	0.00136	CcSEcCtD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000119	0.00253	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	0.000119	0.00253	CbGpPWpGaD
Canagliflozin—Pruritus—Hydrocortisone—ulcerative colitis	0.000119	0.00134	CcSEcCtD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	0.000118	0.00251	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000117	0.00132	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000117	0.00132	CcSEcCtD
Canagliflozin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000117	0.00131	CcSEcCtD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000116	0.00247	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000116	0.00131	CcSEcCtD
Canagliflozin—Urticaria—Dexamethasone—ulcerative colitis	0.000114	0.00128	CcSEcCtD
Canagliflozin—Urticaria—Betamethasone—ulcerative colitis	0.000114	0.00128	CcSEcCtD
Canagliflozin—Dizziness—Prednisolone—ulcerative colitis	0.000114	0.00128	CcSEcCtD
Canagliflozin—Asthenia—Triamcinolone—ulcerative colitis	0.000114	0.00128	CcSEcCtD
Canagliflozin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000113	0.00128	CcSEcCtD
Canagliflozin—Abdominal pain—Betamethasone—ulcerative colitis	0.000113	0.00128	CcSEcCtD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000113	0.00241	CbGpPWpGaD
Canagliflozin—Asthenia—Methylprednisolone—ulcerative colitis	0.000113	0.00128	CcSEcCtD
Canagliflozin—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000113	0.00241	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	0.000113	0.0024	CbGpPWpGaD
Canagliflozin—Pruritus—Triamcinolone—ulcerative colitis	0.000112	0.00126	CcSEcCtD
Canagliflozin—Pruritus—Methylprednisolone—ulcerative colitis	0.000112	0.00126	CcSEcCtD
Canagliflozin—SLC5A1—Disease—MAML2—ulcerative colitis	0.000111	0.00237	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—MAML2—ulcerative colitis	0.000111	0.00237	CbGpPWpGaD
Canagliflozin—Dizziness—Hydrocortisone—ulcerative colitis	0.000111	0.00125	CcSEcCtD
Canagliflozin—Rash—Prednisolone—ulcerative colitis	0.000108	0.00122	CcSEcCtD
Canagliflozin—Dermatitis—Prednisolone—ulcerative colitis	0.000108	0.00122	CcSEcCtD
Canagliflozin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000108	0.0023	CbGpPWpGaD
Canagliflozin—Fatigue—Prednisone—ulcerative colitis	0.000108	0.00121	CcSEcCtD
Canagliflozin—Constipation—Prednisone—ulcerative colitis	0.000107	0.0012	CcSEcCtD
Canagliflozin—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000106	0.00226	CbGpPWpGaD
Canagliflozin—Rash—Hydrocortisone—ulcerative colitis	0.000106	0.00119	CcSEcCtD
Canagliflozin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000106	0.00119	CcSEcCtD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000106	0.00225	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000105	0.00222	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000105	0.00222	CbGpPWpGaD
Canagliflozin—Dizziness—Triamcinolone—ulcerative colitis	0.000105	0.00118	CcSEcCtD
Canagliflozin—Dizziness—Methylprednisolone—ulcerative colitis	0.000104	0.00118	CcSEcCtD
Canagliflozin—ALB—Hemostasis—PROCR—ulcerative colitis	0.000104	0.00222	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	0.000104	0.0022	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000103	0.00219	CbGpPWpGaD
Canagliflozin—Asthenia—Dexamethasone—ulcerative colitis	0.000103	0.00116	CcSEcCtD
Canagliflozin—Asthenia—Betamethasone—ulcerative colitis	0.000103	0.00116	CcSEcCtD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000103	0.00219	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000102	0.00115	CcSEcCtD
Canagliflozin—Nausea—Prednisolone—ulcerative colitis	0.000102	0.00115	CcSEcCtD
Canagliflozin—Pruritus—Dexamethasone—ulcerative colitis	0.000102	0.00114	CcSEcCtD
Canagliflozin—Pruritus—Betamethasone—ulcerative colitis	0.000102	0.00114	CcSEcCtD
Canagliflozin—Nausea—Hydrocortisone—ulcerative colitis	9.98e-05	0.00112	CcSEcCtD
Canagliflozin—Rash—Triamcinolone—ulcerative colitis	9.97e-05	0.00112	CcSEcCtD
Canagliflozin—Dermatitis—Triamcinolone—ulcerative colitis	9.97e-05	0.00112	CcSEcCtD
Canagliflozin—Rash—Methylprednisolone—ulcerative colitis	9.95e-05	0.00112	CcSEcCtD
Canagliflozin—Dermatitis—Methylprednisolone—ulcerative colitis	9.94e-05	0.00112	CcSEcCtD
Canagliflozin—Urticaria—Prednisone—ulcerative colitis	9.93e-05	0.00112	CcSEcCtD
Canagliflozin—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	9.92e-05	0.00211	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	9.91e-05	0.00211	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	9.91e-05	0.00211	CbGpPWpGaD
Canagliflozin—Abdominal pain—Prednisone—ulcerative colitis	9.88e-05	0.00111	CcSEcCtD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	9.71e-05	0.00206	CbGpPWpGaD
Canagliflozin—Dizziness—Dexamethasone—ulcerative colitis	9.49e-05	0.00107	CcSEcCtD
Canagliflozin—Dizziness—Betamethasone—ulcerative colitis	9.49e-05	0.00107	CcSEcCtD
Canagliflozin—Nausea—Triamcinolone—ulcerative colitis	9.4e-05	0.00106	CcSEcCtD
Canagliflozin—Nausea—Methylprednisolone—ulcerative colitis	9.38e-05	0.00106	CcSEcCtD
Canagliflozin—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	9.37e-05	0.00199	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Prednisone—ulcerative colitis	9.21e-05	0.00104	CcSEcCtD
Canagliflozin—ALB—Folate Metabolism—CRP—ulcerative colitis	9.17e-05	0.00195	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CALM3—ulcerative colitis	9.16e-05	0.00195	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CALM3—ulcerative colitis	9.16e-05	0.00195	CbGpPWpGaD
Canagliflozin—Rash—Betamethasone—ulcerative colitis	9.05e-05	0.00102	CcSEcCtD
Canagliflozin—Rash—Dexamethasone—ulcerative colitis	9.05e-05	0.00102	CcSEcCtD
Canagliflozin—Dermatitis—Dexamethasone—ulcerative colitis	9.04e-05	0.00102	CcSEcCtD
Canagliflozin—Dermatitis—Betamethasone—ulcerative colitis	9.04e-05	0.00102	CcSEcCtD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	9.02e-05	0.00192	CbGpPWpGaD
Canagliflozin—Asthenia—Prednisone—ulcerative colitis	8.97e-05	0.00101	CcSEcCtD
Canagliflozin—Pruritus—Prednisone—ulcerative colitis	8.84e-05	0.000996	CcSEcCtD
Canagliflozin—Nausea—Betamethasone—ulcerative colitis	8.53e-05	0.00096	CcSEcCtD
Canagliflozin—Nausea—Dexamethasone—ulcerative colitis	8.53e-05	0.00096	CcSEcCtD
Canagliflozin—SLC5A2—Metabolism—PTGS1—ulcerative colitis	8.52e-05	0.00181	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS1—ulcerative colitis	8.52e-05	0.00181	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—ICAM1—ulcerative colitis	8.43e-05	0.00179	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL10—ulcerative colitis	8.28e-05	0.00176	CbGpPWpGaD
Canagliflozin—Dizziness—Prednisone—ulcerative colitis	8.27e-05	0.000931	CcSEcCtD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.97e-05	0.00169	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.97e-05	0.00169	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	7.91e-05	0.00168	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	7.9e-05	0.00168	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	7.88e-05	0.00168	CbGpPWpGaD
Canagliflozin—Rash—Prednisone—ulcerative colitis	7.88e-05	0.000888	CcSEcCtD
Canagliflozin—Dermatitis—Prednisone—ulcerative colitis	7.87e-05	0.000887	CcSEcCtD
Canagliflozin—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	7.78e-05	0.00165	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CALM3—ulcerative colitis	7.67e-05	0.00163	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CALM3—ulcerative colitis	7.67e-05	0.00163	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.58e-05	0.00161	CbGpPWpGaD
Canagliflozin—Nausea—Prednisone—ulcerative colitis	7.43e-05	0.000836	CcSEcCtD
Canagliflozin—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	7.29e-05	0.00155	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.17e-05	0.00152	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	7.03e-05	0.00149	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	6.74e-05	0.00143	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	6.7e-05	0.00142	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	6.69e-05	0.00142	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	6.66e-05	0.00142	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—ADCY5—ulcerative colitis	6.65e-05	0.00141	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—ADCY5—ulcerative colitis	6.65e-05	0.00141	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS1—ulcerative colitis	6.58e-05	0.0014	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	6.56e-05	0.00139	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	6.52e-05	0.00139	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IFNG—ulcerative colitis	6.41e-05	0.00136	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—RELA—ulcerative colitis	6.33e-05	0.00135	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	6.17e-05	0.00131	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ABCB1—ulcerative colitis	5.97e-05	0.00127	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ABCB1—ulcerative colitis	5.97e-05	0.00127	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CALM3—ulcerative colitis	5.93e-05	0.00126	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CHP1—ulcerative colitis	5.84e-05	0.00124	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL1B—ulcerative colitis	5.72e-05	0.00122	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL2—ulcerative colitis	5.7e-05	0.00121	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ADCY5—ulcerative colitis	5.57e-05	0.00118	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ADCY5—ulcerative colitis	5.57e-05	0.00118	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	5.49e-05	0.00117	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	5.47e-05	0.00116	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—NFKB1—ulcerative colitis	5.34e-05	0.00113	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	5.32e-05	0.00113	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	5.32e-05	0.00113	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	5.1e-05	0.00108	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.1e-05	0.00108	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—DLD—ulcerative colitis	5.04e-05	0.00107	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	5.03e-05	0.00107	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	4.88e-05	0.00104	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	4.87e-05	0.00103	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	4.66e-05	0.000991	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	4.66e-05	0.000991	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ABCB1—ulcerative colitis	4.61e-05	0.000979	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.54e-05	0.000966	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	4.53e-05	0.000962	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	4.5e-05	0.000956	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—TGFB1—ulcerative colitis	4.39e-05	0.000933	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	4.34e-05	0.000923	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—IL2—ulcerative colitis	4.32e-05	0.000919	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ADCY5—ulcerative colitis	4.3e-05	0.000914	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.24e-05	0.000901	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PPARG—ulcerative colitis	4.15e-05	0.000883	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PPARG—ulcerative colitis	4.15e-05	0.000883	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TNF—ulcerative colitis	4.15e-05	0.000882	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—JAK2—ulcerative colitis	4.14e-05	0.000881	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—JAK2—ulcerative colitis	4.14e-05	0.000881	CbGpPWpGaD
Canagliflozin—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	4.12e-05	0.000875	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—GNA12—ulcerative colitis	4.07e-05	0.000865	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	4.03e-05	0.000856	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—ITGAL—ulcerative colitis	4e-05	0.000849	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—CD4—ulcerative colitis	3.93e-05	0.000835	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—CD4—ulcerative colitis	3.93e-05	0.000835	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PTGS2—ulcerative colitis	3.9e-05	0.000829	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PTGS2—ulcerative colitis	3.9e-05	0.000829	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—TGFB1—ulcerative colitis	3.81e-05	0.00081	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ALB—ulcerative colitis	3.73e-05	0.000794	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ALB—ulcerative colitis	3.73e-05	0.000794	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—TP53—ulcerative colitis	3.66e-05	0.000778	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	3.63e-05	0.000772	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.55e-05	0.000755	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	3.37e-05	0.000717	CbGpPWpGaD
Canagliflozin—ALB—Folate Metabolism—IL6—ulcerative colitis	3.35e-05	0.000712	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.31e-05	0.000704	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.31e-05	0.000704	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	3.3e-05	0.000701	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PTGS2—ulcerative colitis	3.27e-05	0.000694	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PTGS2—ulcerative colitis	3.27e-05	0.000694	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PPARG—ulcerative colitis	3.21e-05	0.000681	CbGpPWpGaD
Canagliflozin—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.15e-05	0.00067	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CHP1—ulcerative colitis	3.06e-05	0.00065	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—STAT3—ulcerative colitis	3.04e-05	0.000647	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—STAT3—ulcerative colitis	3.04e-05	0.000647	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.9e-05	0.000617	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALB—ulcerative colitis	2.88e-05	0.000613	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.86e-05	0.000609	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—CALM3—ulcerative colitis	2.83e-05	0.000602	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—TGFB1—ulcerative colitis	2.82e-05	0.000599	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—TGFB1—ulcerative colitis	2.82e-05	0.000599	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CHP1—ulcerative colitis	2.68e-05	0.000569	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.66e-05	0.000566	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	2.66e-05	0.000566	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—DLD—ulcerative colitis	2.64e-05	0.000561	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PTGS2—ulcerative colitis	2.52e-05	0.000536	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	2.48e-05	0.000528	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS1—ulcerative colitis	2.44e-05	0.000518	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	2.4e-05	0.000509	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—DLD—ulcerative colitis	2.31e-05	0.000491	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.3e-05	0.000489	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.22e-05	0.000472	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CALM3—ulcerative colitis	2.19e-05	0.000466	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	2.17e-05	0.000461	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—IL6—ulcerative colitis	2.12e-05	0.000452	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—IL6—ulcerative colitis	2.12e-05	0.000452	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.1e-05	0.000446	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2e-05	0.000425	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.91e-05	0.000405	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—MMP1—ulcerative colitis	1.82e-05	0.000386	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.78e-05	0.000378	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCB1—ulcerative colitis	1.71e-05	0.000363	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.69e-05	0.000359	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.66e-05	0.000354	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.65e-05	0.000351	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ADCY5—ulcerative colitis	1.59e-05	0.000338	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.56e-05	0.000331	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.55e-05	0.00033	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—DLD—ulcerative colitis	1.42e-05	0.000303	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.39e-05	0.000297	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.37e-05	0.000291	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—JAK2—ulcerative colitis	1.28e-05	0.000272	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS1—ulcerative colitis	1.28e-05	0.000271	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PPARG—ulcerative colitis	1.19e-05	0.000252	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CALM3—ulcerative colitis	1.15e-05	0.000244	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.12e-05	0.000238	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IL2—ulcerative colitis	1.12e-05	0.000237	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.1e-05	0.000233	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALB—ulcerative colitis	1.07e-05	0.000227	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.05e-05	0.000222	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CALM3—ulcerative colitis	1.01e-05	0.000214	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PTGS2—ulcerative colitis	9.33e-06	0.000198	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCB1—ulcerative colitis	8.93e-06	0.00019	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TGFB1—ulcerative colitis	8.71e-06	0.000185	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ADCY5—ulcerative colitis	8.33e-06	0.000177	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.3e-06	0.000155	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—TP53—ulcerative colitis	7.17e-06	0.000152	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	6.88e-06	0.000146	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PPARG—ulcerative colitis	6.21e-06	0.000132	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.2e-06	0.000132	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PPARG—ulcerative colitis	5.44e-06	0.000116	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALB—ulcerative colitis	4.89e-06	0.000104	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PTGS2—ulcerative colitis	4.89e-06	0.000104	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	4.82e-06	0.000102	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.5e-06	9.56e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.28e-06	9.1e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.35e-06	7.13e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALB—ulcerative colitis	3.02e-06	6.41e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.64e-06	5.61e-05	CbGpPWpGaD
